# Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

> **NCT00379717** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 30 (estimated)

## Conditions studied

- Non-Small-Cell Lung Carcinoma

## Interventions

- **DRUG:** Cisplatinum
- **DRUG:** Docetaxel
- **DEVICE:** Tomotherapy

## Key facts

- **NCT ID:** NCT00379717
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** 2008-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2008-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00379717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00379717, "Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00379717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*